Skip to main content

Table 4 The frequency of HIF1α isoforms in benign prostate hyperplasia and prostate cancer with and without NE.

From: HIF1α isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation

Table 4 Total nr. HIF1α 1.1 HIF1α 1.2 HIF1α 1.3 HIF1α 12+ HIF1α 12- HIF1α 11-&12- HIF1α 14+ HIF1α 14-
Benign 8 8 (100%) 8 (100%) 0 8 (100%) 8 (100%) 8 (100%) 8 (100%) 8 (100%)
Adenocarcinoma 43 43 (100%) 25 (58%) 0 43 (100%) 43 (100%) 43 (100%) 43 (100%) 43 (100%)
Adenocarcinoma immunopositive for HIF1α 26 26 (100%) 24 (92%) 0 26 (100%) 26 (100%) 26 (100%) 26 (100%) 26 (100%)
Adenocarcinoma immunonegative for HIF1α 17 17 (100%) 1 (6%) 0 17 (100%) 17 (100%) 17 (100%) 17 (100%) 17 (100%)
Adenocarcinoma with NE 22 22 (100%) 19 (86%) 0 22 (100%) 22 (100%) 22 (100%) 22 (100%) 22 (100%)
Adenocarcinoma Without NE 21 21 (100%) 6 (28%) 0 21 (100%) 21 (100%) 21 (100%) 21 (100%) 21 (100%)
LNCaP   + - - + + + + +
  1. The LNCaP cells were used as a control